So you just validated the science in your statement, which is a general contradiction to you “fraud posts”...
Then comes the most investors would be better off if the company had sold. When would that have been?
What value would investors have gotten for the company? Kind of a general bs claim without specifying anything. Which company was going to buy them exactly? You must know since you are certain everyone would have come out ahead.
And patients would be better off. You are certain because a company would not have bought it and stuffed it in its paten arm waiting to ward off any competitor that might make its other very profitable drugs obsolete before their patents are exhausted.
I don’t claim that there was no other way that any company could have done anything better, but your claim here is simply noise to create frustration at this stage. You have no specifics that such options ever really existed, and those are not the facts on the table at this time.
I have been in tiny biotechs that big guys wanted. They are inevitably shorted and shorted so that the buyout is cheap. The buyer looks like a “white knight”, but usually I think the whole set-up is too convenient. They often buy the company with the small company’s deferred tax credits effectively financing the entire purchase.